We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Thales AVS France

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

New Artificial Intelligence Technology Poised to Transform Heart Imaging

By MedImaging International staff writers
Posted on 02 Sep 2021
Print article
Illustration
Illustration
A new artificial intelligence (AI) technology for heart imaging can potentially improve care for patients, allowing doctors to examine their hearts for scar tissue while eliminating the need for contrast injections required for traditional cardiovascular magnetic resonance imaging (MRI).

The team of researchers University Of Virginia (Charlottesville, VA, USA) who developed the technology have reported the success of the approach. The team compared its AI approach, known as virtual native enhancement, with contrast-enhanced cardiovascular magnetic resonance scans now used to monitor hypertrophic cardiomyopathy, the most common genetic heart condition. The researchers found that virtual native enhancement produced higher-quality images and better captured evidence of scar in the heart, all without the need for injecting the standard contrast agent required for cardiovascular magnetic resonance scans.

The new approach works by using AI to enhance “T1-maps” of the heart tissue created by magnetic resonance imaging. These maps are combined with enhanced MRI “cines,” which are like movies of moving tissue – in this case, the beating heart. Overlaying the two types of images creates the artificial virtual native enhancement image. Based on these inputs, the technology can produce something virtually identical to the traditional contrast-enhanced cardiovascular magnetic resonance heart scans doctors are accustomed to reading – only better, the researchers conclude.

The new virtual native enhancement technology will allow doctors to image the heart more often and more quickly, the researchers say. It also may help doctors detect subtle changes in the heart earlier, though more testing is needed to confirm that. The technology also would benefit patients who are allergic to the contrast agent injected for cardiovascular magnetic resonance scans, as well as patients with severely failing kidneys, a group that avoids the use of the agent. While the new research examined virtual native enhancement’s potential in patients with hypertrophic cardiomyopathy, the technology’s creators envision it being used for many other heart conditions as well.

“This is a potentially important advance, especially if it can be expanded to other patient groups,” said researcher Dr. Christopher Kramer, the chief of the Division of Cardiovascular Medicine at UVA Health, Virginia’s only designated Center of Excellence by the Hypertrophic Cardiomyopathy Association. “Being able to identify scar in the heart, an important contributor to progression to heart failure and sudden cardiac death, without contrast, would be highly significant. Cardiovascular magnetic resonance scans would be done without contrast, saving cost and any risk, albeit low, from the contrast agent.”

Related Links:
University of Virginia


Print article
Radcal
CIRS

Channels

Imaging IT

view channel
Illustration

Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology

The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more

Industry News

view channel
Image: GE Healthcare to be Spun Off in 2023 to Create Pure-Play Company at Center of Precision Health (Photo courtesy of GE Healthcare)

GE Healthcare to be Spun Off in 2023 to Create Pure-Play Company at Center of Precision Health

General Electric (GE; Boston, MA, USA) plans to pursue a tax-free spin-off of GE Healthcare, creating a pure-play company at the center of precision health in early 2023. The spin-off of GE Healthcare... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.